HIV Drug Interactions

Around 37 million individuals are living worldwide with HIV and although advances in therapy have yielded effective regimens, individual antiretroviral drugs are amongst the most therapeutically risky for drug-drug interactions (DDI) presenting significant risks to patients and a challenge for health care providers to ensure safe and appropriate prescribing. In order to address this, the Liverpool Drug Interactions website was established in 1999 by members of the Department of Pharmacology at the University of Liverpool to provide a freely available drug-drug interaction resource.全球约有3700万人类免疫缺陷病毒（HIV）感染者。尽管抗病毒治疗领域已取得进展，开发出了有效的治疗方案，但单一抗逆转录病毒药物是发生药物相互作用（drug-drug interactions, DDI）风险最高的药物类别之一。此类相互作用不仅会给患者带来显著健康风险，同时也给医疗保健从业者确保处方安全合理带来了极大挑战。为应对这一问题，利物浦大学药理学系成员于1999年创建了Liverpool Drug Interactions网站，旨在提供可免费获取的药物相互作用相关资源。

搜集汇总

背景与挑战

背景概述

该数据集是一个专注于HIV药物相互作用的在线资源平台，提供免费的药物相互作用检查工具、多语言支持以及教育视频和处方资源。它由利物浦大学药理学系建立，旨在帮助医疗保健提供者确保安全、适当的处方，并包含相关临床支持和社交媒体更新。